These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8553847)

  • 1. Collagen crosslinks in metabolic bone disease.
    Robins SP
    Acta Orthop Scand Suppl; 1995 Oct; 266():171-5. PubMed ID: 8553847
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bone resorption markers].
    Takahashi M; Inoue T
    Rinsho Byori; 1996 May; 44(5):415-22. PubMed ID: 8676559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age- and BMD-related differences in biochemical markers of bone metabolism in rural and urban women from Lublin Region, Poland.
    Filip RS; Zagórski J
    Ann Agric Environ Med; 2004; 11(2):255-9. PubMed ID: 15627333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential.
    Cloos PA; Fledelius C
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):473-80. PubMed ID: 10642504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone markers in osteoporosis and malignancy.
    Lipton A; Costa L; Demers LM
    Can J Oncol; 1995 Dec; 5 Suppl 1():11-5. PubMed ID: 8853519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases.
    Xue Y; Jia W; Zhang H; Dong J; Clemens JD; Tian X
    Chin Med J (Engl); 1999 Feb; 112(2):149-52. PubMed ID: 11593583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview.
    Simsek B; Karacaer O; Karaca I
    Chin Med J (Engl); 2004 Feb; 117(2):291-5. PubMed ID: 14975218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic bone disease in gastrointestinal illness.
    Williams SE; Seidner DL
    Gastroenterol Clin North Am; 2007 Mar; 36(1):161-90, viii. PubMed ID: 17472881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of bone resorption--measurement in serum, plasma or urine?
    Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
    Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis].
    Garnero P; Delmas PD
    Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
    Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an immunoassay method for the determination of urinary collagen crosslink excretion.
    Hata K; Miura M
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():374-5. PubMed ID: 7979105
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biochemical markers of bone turnover. New aspect. An automated assay for measuring bone turnover markers].
    Miura M
    Clin Calcium; 2009 Aug; 19(8):1160-9. PubMed ID: 19638700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
    J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
    Heijckmann AC; Huijberts MS; Schoon EJ; Geusens P; de Vries J; Menheere PP; van der Veer E; Wolffenbuttel BH; Stockbrugger RW; Dumitrescu B; Nieuwenhuijzen Kruseman AC
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):740-7. PubMed ID: 18617778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pyridinium cross-links in the urine. Specific markers of bone resorption in metabolic bone diseases].
    Seibel MJ; Zipf A; Ziegler R
    Dtsch Med Wochenschr; 1994 Jun; 119(25-26):923-9. PubMed ID: 8020391
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer.
    Kanakis I; Nikolaou M; Pectasides D; Kiamouris C; Karamanos NK
    J Pharm Biomed Anal; 2004 Mar; 34(4):827-32. PubMed ID: 15019061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical markers of bone metabolism: application to understanding bone remodeling in children and adolescents.
    Levine MA
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():661-72. PubMed ID: 12795369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Do bone turnover markers have clinical significance].
    Välimäki M
    Duodecim; 1996; 112(22):2114-20. PubMed ID: 10605217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.